CCR 20th anniversary commentary: Stayin' alive-antiapoptotic proteins and breast cancer

Douglas Yee

doi:10.1158/1078-0432.CCR-14-2548

CCR 20^th anniversary commentary: Stayin' alive-antiapoptotic proteins and breast cancer

Douglas Yee

Medicine - Hematology, Oncology, Transplant

Research output: Contribution to journal › Review article › peer-review

Abstract

The control of cell death involves a complex interaction of multiple proteins. In a study published in the January 1, 2000, issue of Clinical Cancer Research, Tanaka and colleagues demonstrated that one of the proapoptotic proteins, survivin, was frequently expressed in breast cancer. In the subsequent years, effectors of apoptosis have translated into important prognostic indicators and potential therapeutic targets.

Original language	English (US)
Pages (from-to)	665-666
Number of pages	2
Journal	Clinical Cancer Research
Volume	21
Issue number	4
DOIs	https://doi.org/10.1158/1078-0432.CCR-14-2548
State	Published - Feb 15 2015

Bibliographical note

Publisher Copyright:
© 2015 American Association for Cancer Research.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1158/1078-0432.CCR-14-2548

OpenUrl availability

Full text

Cite this

@article{4c511d0538d243f89ea4185163a75293,

title = "CCR 20th anniversary commentary: Stayin' alive-antiapoptotic proteins and breast cancer",

abstract = "The control of cell death involves a complex interaction of multiple proteins. In a study published in the January 1, 2000, issue of Clinical Cancer Research, Tanaka and colleagues demonstrated that one of the proapoptotic proteins, survivin, was frequently expressed in breast cancer. In the subsequent years, effectors of apoptosis have translated into important prognostic indicators and potential therapeutic targets.",

author = "Douglas Yee",

note = "Publisher Copyright: {\textcopyright} 2015 American Association for Cancer Research.",

year = "2015",

month = feb,

day = "15",

doi = "10.1158/1078-0432.CCR-14-2548",

language = "English (US)",

volume = "21",

pages = "665--666",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "4",

}

TY - JOUR

T1 - CCR 20th anniversary commentary

T2 - Stayin' alive-antiapoptotic proteins and breast cancer

AU - Yee, Douglas

PY - 2015/2/15

Y1 - 2015/2/15

N2 - The control of cell death involves a complex interaction of multiple proteins. In a study published in the January 1, 2000, issue of Clinical Cancer Research, Tanaka and colleagues demonstrated that one of the proapoptotic proteins, survivin, was frequently expressed in breast cancer. In the subsequent years, effectors of apoptosis have translated into important prognostic indicators and potential therapeutic targets.

AB - The control of cell death involves a complex interaction of multiple proteins. In a study published in the January 1, 2000, issue of Clinical Cancer Research, Tanaka and colleagues demonstrated that one of the proapoptotic proteins, survivin, was frequently expressed in breast cancer. In the subsequent years, effectors of apoptosis have translated into important prognostic indicators and potential therapeutic targets.

UR - http://www.scopus.com/inward/record.url?scp=84923193711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923193711&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-14-2548

DO - 10.1158/1078-0432.CCR-14-2548

M3 - Review article

C2 - 25691771

AN - SCOPUS:84923193711

SN - 1078-0432

VL - 21

SP - 665

EP - 666

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 4

ER -